Know the words on the page.
With telehealth, the care discussion takes place by screen, phone, or messages exchanged online. The health professional who assesses your concern is called a clinician.
A peptide is a small substance made of tiny parts joined in a short chain. Insulin is one example. The peptide label tells you about a substance’s make-up; it does not settle whether medical use is allowed, as of September 2026.
FDA is the short name of the US medicine review agency, the Food and Drug Administration.
FDA approval tells you that an exact medicine product was reviewed and accepted to treat a named condition, as of September 2026.
The medicine name for human growth hormone is somatropin, and FDA-approved US products exist as of September 2026.
Ask for the actual product name rather than a broad label such as hormone care.
Expect time to talk through your care.
The Federation of State Medical Boards says in its September 2026 guidance that choosing medicine from a menu alone falls below the care standard.
That group brings together state medical boards, which oversee doctors. As of September 2026, this guidance offers boards a model to follow; it does not set a nationwide law.
Its guidance also calls for a route to the health professional when patients have follow-up questions.
Ask how questions are answered. Ask what happens if the health professional needs more information.
Put your concern into a short note.
Write what brought you here and what you hope to learn. Include your current medicines, along with test results you would like to talk about.
Bring a cost question too: what does the assessment fee cover if no prescription is given?